Chemotherapy of acute myeloblastic leukaemia with DAM regimen.
Bangladesh Med Res Counc Bull
;
1997 Dec; 23(3): 82-6
Artigo
em Inglês
| IMSEAR
| ID: sea-470
ABSTRACT
32 patients of denovo-ANLL were treated with Doxorubicin, Ara-C and 6-Mercaptopurine (DAM) regimen. Remission induction was instituted with 1-3 cycles of DAM regimen and maintenance was given by 6-MP continuously with intermittent DA (1,5) regimen. In the remission induction, Doxorubicin 30 mg/m2 for 3 days, Ara-C 150 mg/m2 for 5 days and 6-Mp 100 mg/m2 daily was given. Complete remission (CR) was observed in 60% cases. The probability of 2 years disease-free survival of patients with complete remission is 56.73%.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Contagem de Células Sanguíneas
/
Indução de Remissão
/
Feminino
/
Humanos
/
Masculino
/
Esquema de Medicação
/
Leucemia Mieloide Aguda
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Doxorrubicina
/
Intervalo Livre de Doença
Idioma:
Inglês
Revista:
Bangladesh Med Res Counc Bull
Ano de publicação:
1997
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS